Source: Archiv der Pharmazie Chemistry in Life Science. Unidade: FCF
Subjects: DOENÇA DE ALZHEIMER, MODELAGEM MOLECULAR
ABNT
FERNANDES, Thais Batista et al. Synthesis, molecular modeling, and evaluation of novel sulfonylhydrazones as acetylcholinesterase inhibitors for Alzheimer's disease. Archiv der Pharmazie Chemistry in Life Science, v. 350, n. 11, p. 1-16 art.e1700163, 2017Tradução . . Disponível em: https://doi.org/10.1002/ardp.201700163. Acesso em: 23 ago. 2024.APA
Fernandes, T. B., Cunha, M. R., Sakata, R. P., Cândido, T. M., Baby, A. R., Tavares, M. T., et al. (2017). Synthesis, molecular modeling, and evaluation of novel sulfonylhydrazones as acetylcholinesterase inhibitors for Alzheimer's disease. Archiv der Pharmazie Chemistry in Life Science, 350( 11), 1-16 art.e1700163. doi:10.1002/ardp.201700163NLM
Fernandes TB, Cunha MR, Sakata RP, Cândido TM, Baby AR, Tavares MT, Barbosa EG, Almeida WP, Parise Filho R. Synthesis, molecular modeling, and evaluation of novel sulfonylhydrazones as acetylcholinesterase inhibitors for Alzheimer's disease [Internet]. Archiv der Pharmazie Chemistry in Life Science. 2017 ; 350( 11): 1-16 art.e1700163.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1002/ardp.201700163Vancouver
Fernandes TB, Cunha MR, Sakata RP, Cândido TM, Baby AR, Tavares MT, Barbosa EG, Almeida WP, Parise Filho R. Synthesis, molecular modeling, and evaluation of novel sulfonylhydrazones as acetylcholinesterase inhibitors for Alzheimer's disease [Internet]. Archiv der Pharmazie Chemistry in Life Science. 2017 ; 350( 11): 1-16 art.e1700163.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1002/ardp.201700163